A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD
Clinical trial NCT07269769 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07269769
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2031-12-31
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.